Gene-editing beyond CRISPR refers to advanced genetic engineering techniques that allow for precise modifications to the DNA sequence of living cells without causing double-strand breaks. These methods include base editors and prime editors.
Traditional CRISPR-based methods often rely on creating double-strand breaks, which can lead to off-target effects and genomic instability. Gene-editing beyond CRISPR addresses these issues by providing more precise modifications that are less likely to cause unintended mutations or cell death.
These technologies utilize enzymes such as cytosine or adenine base editors, which can directly convert one base pair into another within the genome, and prime editors that can make both single-base changes and insertions/deletions in a single step. They operate by fusing an enzyme with a guide RNA to target specific DNA sequences for modification.
The manufacturing process involves the synthesis of guide RNAs for specific target sequences, production of the gene editors (enzymes), and integration into delivery vehicles such as viral vectors. The materials required include DNA templates, enzymes, RNA molecules, and vector systems.
The build process typically starts with designing the guide RNA to match the desired genomic locus. Next, the appropriate base editor or prime editor is selected based on the type of modification needed. Finally, these components are packaged into delivery vehicles like lentiviral vectors for efficient cellular uptake.
Curated names only — none are invented. Use the link to find more.
Cost drivers only — no verified dollar figures are shown. Check live sources for prices.
Illustrative — search real, dated examples rather than trusting a generated story.
Live searches — we don't list papers we can't verify.
Live patent searches — filings are never listed from memory.
Verify against primary sources only.
Source: curated technology intelligence stream with tracked references.